Qualifications
- PhD: Tumour suppressor regulation of tumour immune interactions in lung adenocarcinoma
Barts and the London School of Medicine and Dentistry, 2017–2020
Teaching and Supervision
Module MSE-4041: Human Immunology & Disease
Module MSE-4042: Laboratory Molecular Research
Research Interests
The Kennedy group is focused on molecular pathways which govern epithelial-immune cell interactions, specifically in the context of tumour microenvironments and autoinflammatory disorders. Effective immune tolerance is essential for tissue homeostasis and is frequently compromised in the pathogenesis of autoimmunity and cancer. We aim to study the molecular immunology of disease mechanisms with the ultimate goal of identifying new opportunities for immunotherapy.
Postgraduate Project Opportunities
I am willing to supervise a PhD
Publications
2025
- PublishedCTLA-4-two pathways to anti-tumour immunity?
Ward, F. J., Kennedy, P. T., Al-Fatyan, F., Dahal, L. N. & Abu-Eid, R., 22 Apr 2025, In: Immunotherapy advances. 5, 1, ltaf008.
Research output: Contribution to journal › Review article › peer-review
2024
- PublishedDifferential Regulation of the STING Pathway in Human Papillomavirus-Positive and -Negative Head and Neck Cancers
Saulters, E. L., Kennedy, P. T., Carter, R. J., Alsufyani, A., Jones, T. M., Woolley, J. F. & Dahal, L. N., 16 Jan 2024, In: Cancer research communications. 4, 1, p. 118-133 16 p.
Research output: Contribution to journal › Article › peer-review - PublishedSoluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunity
Kennedy, P. T., Saulters, E. L., Duckworth, A. D., Lim, Y. J., Woolley, J. F., Slupsky, J. R., Cragg, M. S., Ward, F. J. & Dahal, L. N., 7 Feb 2024, In: Molecular therapy : the journal of the American Society of Gene Therapy. 32, 2, p. 457-468 12 p.
Research output: Contribution to journal › Article › peer-review
2023
- PublishedNeuroblastoma: an ongoing cold front for cancer immunotherapy
Kennedy, P. T., Zannoupa, D., Son, M. H., Dahal, L. N. & Woolley, J. F., 22 Nov 2023, In: Journal for immunotherapy of cancer. 11, 11, e007798.
Research output: Contribution to journal › Review article › peer-review
2021
- PublishedInvestigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review
Wells, G., Kennedy, P. T. & Dahal, L. N., 10 Mar 2021, In: Frontiers in immunology. 12, 651687.
Research output: Contribution to journal › Article › peer-review - PublishedZinc Status Alters Alzheimer's Disease Progression through NLRP3-Dependent Inflammation
Rivers-Auty, J., Tapia, V. S., White, C. S., Daniels, M. J. D., Drinkall, S., Kennedy, P. T., Spence, H. G., Yu, S., Green, J. P., Hoyle, C., Cook, J., Bradley, A., Mather, A. E., Peters, R., Tzeng, T.-C., Gordon, M. J., Beattie, J. H., Brough, D. & Lawrence, C. B., 31 Mar 2021, In: Journal of Neuroscience. 41, 13, p. 3025-3038 14 p.
Research output: Contribution to journal › Article › peer-review
2018
- PublishedA HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia
Foxler, D. E., Bridge, K. S., Foster, J. G., Grevitt, P., Curry, S., Shah, K. M., Davidson, K. M., Nagano, A., Gadaleta, E., Rhys, H. I., Kennedy, P. T., Hermida, M. A., Chang, T.-Y., Shaw, P. E., Reynolds, L. E., McKay, T. R., Wang, H.-W., Ribeiro, P. S., Plevin, M. J. & Lagos, D. & 7 others, Lemoine, N. R., Rajan, P., Graham, T. A., Chelala, C., Hodivala-Dilke, K. M., Spendlove, I. & Sharp, T. V., Aug 2018, In: EMBO molecular medicine. 10, 8, 18 p., e8304.
Research output: Contribution to journal › Article › peer-review